Leili Shokoohizadeh

Co-production of ESBL and OXA-48 in 3 of 67 isolates, with a unique NDM-1/OXA-48 co-producing strain from a pediatric ALL patient: a case series

Abstract Background Antibiotic resistance poses a major challenge in treating bloodstream infections (BSI) from Escherichia coli in patients with leukemia. Imipenem, a carbapenem antibiotic and, is considered an effective option for treating bloodstream infections in patients wit...